Medicine and Dentistry
Myocardial Infarction
91%
Percutaneous Coronary Intervention
86%
ST Segment Elevation Myocardial Infarction
76%
Acute Coronary Syndrome
59%
Primary Percutaneous Coronary Intervention
52%
Acute Heart Infarction
49%
Umirolimus
48%
Rapamycin
42%
Cardiac Magnetic Resonance Imaging
42%
Cardiovascular System
40%
Severe Mental Illness
34%
Drug-Eluting Stent
34%
Infarction
34%
Target Lesion
34%
All Cause Mortality
31%
Cardiovascular Disease
31%
Hazard Ratio
28%
Bipolar Disorder
27%
Revascularization
26%
Heart Failure
25%
Randomized Controlled Trial
24%
Diseases
24%
Population
23%
Influenza Vaccination
23%
Diabetes
23%
Odds Ratio
22%
Placebo
22%
Coronary Artery Disease
22%
Cohort Analysis
22%
Stenting
22%
Heart Death
21%
Cause of Death
21%
Stent Thrombosis
20%
Cardiovascular Risk
20%
Randomized Clinical Trial
20%
Diabetes Mellitus
19%
Antiplatelet
19%
Arteriosclerosis Obliterans
18%
Isotopes of Calcium
18%
Major Adverse Cardiac Event
16%
Target Lesion Revascularization
16%
Mortality Rate
16%
Apoplexy
16%
Patient with Diabetes
15%
Coronary Angiography
15%
Noninferiority Trial
14%
Coronary Artery Bypass Graft
14%
Clinical Trial
14%
Q Wave
13%
Influenza Vaccine
13%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Infarction
100%
ST Segment Elevation Myocardial Infarction
62%
Rapamycin
56%
Umirolimus
56%
Acute Coronary Syndrome
56%
Infarction
47%
Acute Heart Infarction
42%
All Cause Mortality
35%
Cardiovascular Disease
30%
Major Adverse Cardiac Event
30%
Bipolar Disorder
27%
Stent Thrombosis
26%
Heart Failure
25%
Heart Death
24%
Peripheral Occlusive Artery Disease
24%
Prevalence
23%
Coronary Artery Disease
21%
CD34 Antibody
17%
Vaccination Policy
17%
Clinical Trial
17%
Disease
17%
Cardiovascular Risk
16%
Mortality Rate
16%
Placebo
16%
Randomized Clinical Trial
15%
Cohort Study
15%
Anterior Myocardial Infarction
13%
Cardiovascular Mortality
13%
Reperfusion Injury
12%
Melatonin
11%
Coronary Artery Calcification
11%
Randomized Controlled Trial
11%
Cause of Death
11%
Diabetes Mellitus
10%
Ischemia
9%
Atrial Fibrillation
9%
Beta Adrenergic Receptor Blocking Agent
9%
Influenza Vaccine
9%
Comorbidity
8%
Noninferiority Trial
8%
Heart Arrest
8%
Antiplatelet
7%
Ischemic Heart Disease
7%
Heart Muscle Ischemia
7%
Psychotropic Agent
6%
Bleeding
6%
Gadolinium
6%
Non ST Segment Elevation Myocardial Infarction
6%
Symptom
6%
Stainless Steel
6%
Keyphrases
Myocardial Infarction
39%
Clinical Outcome
38%
Patients with Schizophrenia
29%
Acute Coronary Syndrome
26%
Orsiro Stent
23%
ST-elevation Myocardial Infarction (STEMI)
20%
Stent
19%
Sirolimus
18%
Bipolar Disorder
17%
Confidence Interval
17%
Percutaneous Coronary Intervention
16%
All-cause Mortality
15%
Diabetes
15%
Biodegradable Polymers
13%
Revascularization
13%
Mortality Rate
12%
Schizophrenia
12%
Target Lesion Failure
12%
Anti-CD34 Antibody
11%
Temporal Trends
11%
Major Adverse Cardiovascular Events
11%
Randomized Clinical
11%
Schizophrenia Symptoms
11%
Clinical Comparison
11%
Peripheral Arterial Disease
11%
Primary Percutaneous Coronary Intervention
11%
Dual Therapy
11%
Cardiovascular Disease
10%
Coronary Artery Disease
10%
Stent Implantation
10%
Adverse Cardiac Events
9%
Hazard Ratio
9%
Target Lesion Revascularization
8%
Increased Mortality
8%
Biolimus-eluting Stent
7%
Cardiac Death
7%
Severe Mental Illness
7%
Stent Thrombosis
7%
Comorbidity
7%
Cardiovascular Mortality
7%
Myocardial Salvage Index
7%
Beta-blockers
6%
Left Ventricular Ejection Fraction
6%
Clinical Trials
6%
Polymer-free
6%
Ultra-thin Strut
6%
Register-based
6%
Patients with Diabetes
6%
Life Expectancy
6%
Somatic Symptoms
6%